{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:44:27Z","timestamp":1794926667749,"version":"4.9.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      The nucleotide-binding oligomerization domain [NOD-], leucine-rich repeats [LRR-], and Pyrin domain-containing protein 3 (NLRP3) inflammasome plays an essential role in hypertension-related atrial fibrillation (AF). p300 is involved in cardiovascular inflammation. In this study, we aimed to investigate the role of p300 in NLRP3 inflammasome activation and its subsequent impact on the I\n                      <jats:sub>kur<\/jats:sub>\n                      current in angiotensin II (Ang II)-induced HL-1 cells and Ang II-infused mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Expression levels of p300, Kv1.5, and NLRP3 in left atrial appendage (LAA) tissues from AF and participants with sinus rhythm (SR) were detected by Western blot. A hypertension mouse model was established in\n                      <jats:italic toggle=\"yes\">p300<\/jats:italic>\n                      knockout (\n                      <jats:italic toggle=\"yes\">p300<\/jats:italic>\n                      -KO) mice\n                      <jats:italic toggle=\"yes\">via<\/jats:italic>\n                      Ang II infusion, and AF incidence was assessed by electrocardiogram (ECG) after rapid atrial pacing.\n                      <jats:italic toggle=\"yes\">In vitro<\/jats:italic>\n                      , the expression level of p300 in HL-1 cells was modulated by adenoviral overexpression, curcumin (an inhibitor of p300) treatment, and small interfering RNA (siRNA) knockdown. NLRP3 inflammasome activation was evaluated by Western blot and enzyme-linked immunosorbent assay, and electrophysiological properties of HL-1 cells were analyzed using whole-cell patch-clamp recordings. Co-immunoprecipitation assays were performed to investigate the interaction between p300 and nuclear factor kappa B (NF-\u03baB).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The expression levels of p300, Kv1.5, and NLRP3 were found to be significantly higher in the LAA tissue of AF patients compared to SR patients.\n                      <jats:italic toggle=\"yes\">p300<\/jats:italic>\n                      -KO decreased AF incidence in Ang II-infused mice by impairing NLRP3 inflammasome activation.\n                      <jats:italic toggle=\"yes\">p300<\/jats:italic>\n                      -OE facilitated NLRP3 inflammasome activation, which subsequently increased the I\n                      <jats:sub>kur<\/jats:sub>\n                      density and shortened the action potential duration of HL-1 cells. Both curcumin and\n                      <jats:italic toggle=\"yes\">p300<\/jats:italic>\n                      -siRNA treatments reversed Ang II-induced atrial electrical remodeling and NLRP3 inflammasome activation. Moreover, co-immunoprecipitation showed that p300 interacts with NF-\u03baB to promote NLRP3 inflammasome activation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      p300 participates in hypertension-induced AF susceptibility by interacting with NF-\u03baB to activate the NLRP3 inflammasome, which subsequently upregulates the transmembrane current of I\n                      <jats:sub>kur<\/jats:sub>\n                      in atrial cardiomyocytes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003501","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:01:09Z","timestamp":1739923269000},"page":"576-588","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["p300 upregulates Ikur in atrial cardiomyocytes through activating NLRP3 inflammasome in hypertension"],"prefix":"10.1097","volume":"139","author":[{"given":"Long","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panyue","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China"},{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Rao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Du","sequence":"additional","affiliation":[{"name":"Dongguan Tungwah Songshan Lake Hospital, Dongguan, Guangdong 523820, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghuan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China"},{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Deng","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhou","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China"},{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China"},{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhong","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China"},{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China"},{"name":"Guangdong Provincial Key Laboratory of Clinical Pharmacology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Guangdong 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"R1-20260220","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/CIRCULATIONAHA.117.031431","article-title":"Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation","volume":"137","author":"Weng","year":"2018","journal-title":"Circulation"},{"key":"R2-20260220","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"issue":"23","key":"R3-20260220","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1097\/CM9.0000000000003902","article-title":"2024 annual report on cardiovascular health and diseases in China: Data and trend","volume":"138","author":"Liu","year":"2025","journal-title":"Chin Med J"},{"key":"R4-20260220","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/CM9.0000000000002471","article-title":"Prevalence and clinical characteristics of atrial fibrillation in hospitalized patients with coronary artery disease and hypertension: a cross-sectional study from 2008 to 2018","volume":"136","author":"Xin","year":"2023","journal-title":"Chin Med J"},{"key":"R5-20260220","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/HJH.0000000000003278","article-title":"Hypertension and atrial fibrillation","volume":"40","author":"Middeldorp","year":"2022","journal-title":"J Hypertens"},{"key":"R6-20260220","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41371-019-0279-7","article-title":"Invited review: Hypertension and atrial fibrillation: Epidemiology, pathophysiology, and implications for management","volume":"33","author":"Gumprecht","year":"2019","journal-title":"J Hum Hypertens"},{"key":"R7-20260220","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/ph14121303","article-title":"Peptide inhibitors of Kv1.5: An option for the treatment of atrial fibrillation","volume":"14","author":"Borrego","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"R8-20260220","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1152\/physrev.00024.2019","article-title":"Cardiac transmembrane ion channels and action potentials: Cellular physiology and arrhythmogenic behavior","volume":"101","author":"Varr\u00f3","year":"2021","journal-title":"Physiol Rev"},{"key":"R9-20260220","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1113\/jphysiol.2013.256115","article-title":"Atrial selectivity of antiarrhythmic drugs","volume":"591","author":"Ravens","year":"2013","journal-title":"J Physiol"},{"key":"R10-20260220","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/CIRCRESAHA.114.302711","article-title":"Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes","volume":"114","author":"Schumacher-Bass","year":"2014","journal-title":"Circ Res"},{"key":"R11-20260220","doi-asserted-by":"crossref","first-page":"916","DOI":"10.14336\/AD.2020.0401","article-title":"p300 in cardiac development and accelerated cardiac aging","volume":"11","author":"Ghosh","year":"2020","journal-title":"Aging Dis"},{"key":"R12-20260220","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/15592294.2017.1370173","article-title":"A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis","volume":"12","author":"Rai","year":"2017","journal-title":"Epigenetics"},{"key":"R13-20260220","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/cvr\/cvab024","article-title":"NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias","volume":"117","author":"Scott","year":"2021","journal-title":"Cardiovasc Res"},{"key":"R14-20260220","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.1701495","article-title":"Curcumin suppresses IL-1\u03b2 secretion and prevents inflammation through inhibition of the NLRP3 inflammasome","volume":"200","author":"Yin","year":"2018","journal-title":"J Immunol"},{"key":"R15-20260220","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The losartan intervention for end point reduction in hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R16-20260220","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106881","article-title":"Angiotensin-II activates vascular inflammasome and induces vascular damage","volume":"139","author":"Cau","year":"2021","journal-title":"Vascul Pharmacol"},{"key":"R17-20260220","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13743","article-title":"Acetyltransferase p300 regulates atrial fibroblast senescence and age-related atrial fibrosis through p53\/Smad3 axis","volume":"22","author":"Gao","year":"2023","journal-title":"Aging Cell"},{"key":"R18-20260220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/1440-1681.13580","article-title":"Connexin 43 participates in atrial electrical remodeling through colocalization with calcium channels in atrial myocytes","volume":"49","author":"Peng","year":"2022","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R19-20260220","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.842885","article-title":"Piezo1 participated in decreased L-type calcium current induced by high hydrostatic pressure via. CaM\/Src\/Pitx2 activation in atrial myocytes","volume":"9","author":"Fang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R20-20260220","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1002\/jcp.26337","article-title":"Involvement of Smad3 pathway in atrial fibrosis induced by elevated hydrostatic pressure","volume":"233","author":"Wei","year":"2018","journal-title":"J Cell Physiol"},{"key":"R21-20260220","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102704","article-title":"Acetylation of p65Lys310 by p300 in macrophages mediates anti-inflammatory property of berberine","volume":"62","author":"Zhang","year":"2023","journal-title":"Redox Biol"},{"key":"R22-20260220","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.862164","article-title":"Role of inflammation in the pathogenesis of atrial fibrillation","volume":"13","author":"Ihara","year":"2022","journal-title":"Front Physiol"},{"key":"R23-20260220","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1097\/CM9.0000000000002906","article-title":"Atrial fibrillation: Mechanism and clinical management","volume":"136","author":"Hu","year":"2023","journal-title":"Chin Med J"},{"key":"R24-20260220","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/med.21781","article-title":"NLRP3 inflammasome in cardiovascular diseases: Pathophysiological and pharmacological implications","volume":"41","author":"Pellegrini","year":"2021","journal-title":"Med Res Rev"},{"key":"R25-20260220","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/cells9071642","article-title":"The NLRP3 inflammasome role in the pathogenesis of pregnancy induced hypertension and preeclampsia","volume":"9","author":"Socha","year":"2020","journal-title":"Cells"},{"key":"R26-20260220","doi-asserted-by":"crossref","first-page":"H1015","DOI":"10.1152\/ajpheart.00023.2006","article-title":"Cardiac fibroblasts: Friend or foe?","volume":"291","author":"Baudino","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R27-20260220","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"R28-20260220","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/pace.12182","article-title":"Assessment of interleukin-1\u00a0gene cluster polymorphisms in lone atrial fibrillation: New insight into the role of inflammation in atrial fibrillation","volume":"36","author":"Gungor","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"R29-20260220","article-title":"C646 protects against DSS-induced colitis model by targeting NLRP3 inflammasome","volume":"12","author":"Xu","year":"2021","journal-title":"Front Pharmacol"},{"key":"R30-20260220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.intimp.2019.01.046","article-title":"Curcumin attenuates murine lupus via inhibiting NLRP3 inflammasome","volume":"69","author":"Zhao","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"R31-20260220","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/mnfr.201500316","article-title":"Curcumin suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock","volume":"59","author":"Gong","year":"2015","journal-title":"Mol Nutr Food Res"},{"key":"R32-20260220","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/cvr\/cvab114","article-title":"Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome","volume":"118","author":"Zhang","year":"2022","journal-title":"Cardiovasc Res"},{"key":"R33-20260220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"R34-20260220","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J Immunol"},{"key":"R35-20260220","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.820541","article-title":"Canagliflozin ameliorates NLRP3 inflammasome-mediated inflammation through inhibiting NF-\u03baB signaling and upregulating Bif-1","volume":"13","author":"Niu","year":"2022","journal-title":"Front Pharmacol"},{"key":"R36-20260220","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: An overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:00:52Z","timestamp":1771563652000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003501","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"2024-07-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}